Instagram post (direct link, archive link) shows a syringe extracting fluid from a vial and claims a cure has been developed ...
Psychedelic industry faced setbacks, cannabis was almost rescheduled and overdose deaths dropped — but not for all ...
That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...
Science magazine has chosen twice-yearly lenacapavir PrEP as its 2024 Breakthrough of the Year, recognizing it as a ...
Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.
Lenacapavir, a preventive HIV drug, could become accessible in low-income countries by 2026. Efforts spearheaded by global ...
This drug helps manage infections and prevent AIDS, but claims it’s a ‘cure’ are not supported
Though the post doesn’t specify, the two shots per year for HIV treatment that costs around $40,000 may refer to the injectable drug lenacapavir. The Food and Drug Administration approved lenacapavir ...
While the efficacy of twice-yearly subcutaneous lenacapavir for HIV prevention has previously been demonstrated in cisgender ...
By 2025, a new HIV preventive drug, lenacapavir, could be available to the world's poorest regions. The Global Fund aims to ...
Biotech giant Gilead Sciences, Inc. GILD has put up a steady performance in 2024 amid a volatile market. Its shares have ...
A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global ...
The post appears to reference the drug lenacapavir, which reportedly can cost around $40,000 annually in the U.S. and is administered in twice-yearly doses. While the drug appears to be effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback